Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, sometimes via third party companies, which offer retrospective financial rebates to Greater Manchester Integrated Care Board (GMICB) based on primary care prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or the GMMMG formulary.

All rebate applications are assessed against the GMMMG Ethical Framework for Primary Care Rebate schemes, which can be found at the bottom of this page along with the application form.

Please direct any enquiries regarding primary care rebate schemes to

The primary care rebate schemes to which GMICB has signed up are as follows:

CompanyProductStart dateEnd date
Chiesi LtdFostair NEXTHaler dpi01/10/202230/09/2025
Chiesi LtdFostair pMDI01/10/202230/09/2025
Chiesi LtdClenil01/10/202230/09/2024
Ferring Pharmaceuticals LtdFirmagon01/07/202231/12/2024
Flynn Pharma LtdSlenyto01/04/202431/03/2027
Luye PharmaFencino01/07/202230/11/2024
Merck Serono LtdGlucophage SR01/07/202230/06/2024
Takeda LtdProstap01/07/202230/06/2024
Viatris UK Healthcare LtdSirdupla01/07/202231/03/2025

Expired rebate schemes

CompanyProductStart dateEnd date
Sandoz Ltd AirFluSal Forspiro 01/07/202230/03/2023

Document Title Issue Date Review Date Status
Ethical Framework for Primary Care Rebate Applications 20240618 Jun 2024 20270418 Apr 2027 Version 10
Primary Care Rebate Scheme Application form 20220918 Sep 2022 Version 5.1